InsidersTradesSigma
Follow the Indoco Remedies share price and the full management transaction log of the company, a publicly traded company based in India. Shares are quoted on the IN market, under the supervision of SEBI (PIT + SAST). The latest transaction was disclosed on 9 September 2026 (Acquisition). Among the most active insiders: ADITI M. PANANDIKAR. The full history is accessible without an account.
6
Insider Decl.
n/a
Thresholds
€105,585
6 ops.
Buy Volume
n/a
n/a
Sell Volume
35Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 9 September 2026
Declarations6 total
14,534 shares@ ₹237.90EquityMarket PurchaseSEBI:3f0185aae028a2660421a3b17985dfa04ebdd7ed
Canonical exit: 8 Dec 2026 (T+90)
4,970 shares@ ₹235.70EquityMarket PurchaseSEBI:1c397555ab44576ea413c63f88c16e4f986ed6bf
Canonical exit: 8 Dec 2026 (T+90)
4,900 shares@ ₹235.70EquityMarket PurchaseSEBI:4e57b0708c7b6e7fce87fa7ced1a53a1ac788612
Canonical exit: 8 Dec 2026 (T+90)
14,526 shares@ ₹238.30EquityMarket PurchaseSEBI:3a11acf2362403cf37edc6b7cd5beb33cd68c602
Canonical exit: 8 Dec 2026 (T+90)
5,000 shares@ ₹244.80100.0% of flowEquityMarket PurchaseSEBI:4e4ee6c5dffe21ae7ab420976d3a8368816b1e63
Canonical exit: 29 Nov 2026 (T+90)
5,000 shares@ ₹244.80100.0% of flowEquityMarket PurchaseSEBI:53c9daad1c3cbe91081feee40aeab91d13f6a89c
Canonical exit: 29 Nov 2026 (T+90)
6 of 6 declarations
About Indoco Remedies
Indoco Remedies is an Indian pharmaceutical company specializing in the manufacture of generic drugs and health products. It is listed on the Bombay Stock Exchange.